"10.1371_journal.pone.0041191","plos one","2012-07-27T00:00:00Z","Xiomara V Thomas; Joep de Bruijne; James C Sullivan; Tara L Kieffer; Cynthia K Y Ho; Sjoerd P Rebers; Michel de Vries; Hendrik W Reesink; Christine J Weegink; Richard Molenkamp; Janke Schinkel","Academic Medical Center, Department of Medical Microbiology, Section of Clinical Virology, Amsterdam, The Netherlands; Academic Medical Center, Department of Gastroenterology and Hepatology, Amsterdam, The Netherlands; Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America; Academic Medical Center, Department of Medical Microbiology, Section of Human Retro Virology, Amsterdam, The Netherlands","Conceived and designed the experiments: XVT JdB J. Schinkel RM HR. Performed the experiments: XVT SPR. Analyzed the data: XVT RM J. Schinkel CKYH TK J. Sullivan. Contributed reagents/materials/analysis tools: MdV RM TK J. Sullivan. Wrote the paper: XVT JdB J. Schinkel. Helped with study set-up: CJW.","The authors have read the journals policy and have the following conflicts: HR serves as advisor for Roche Molecular Diagnostics, Anadys, Merck, Arrows, and Gilead, consults for PRA-International, Tibotec, GlaxoSmithKline, Chiron Novartis, and Roche Therapeutics, and receives grant/research support from Merck & Co. TK and J. Sullivan are employees and stock owners of Vertex Pharmaceuticals Incorporated. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials. All other authors have nothing to disclose.","2012","07","Xiomara V Thomas","XVT",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
